Suicidality and self‐injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing

Objective Meta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non‐suicidal self‐injury (NSSI) associated with SSRI treatment in a cli...

Full description

Saved in:
Bibliographic Details
Published in:Acta psychiatrica Scandinavica Vol. 145; no. 2; pp. 209 - 222
Main Authors: Sørensen, Johanne Østerby, Rasmussen, Annette, Roesbjerg, Troels, Verhulst, Frank C., Pagsberg, Anne Katrine
Format: Journal Article
Language:English
Published: United States Blackwell Publishing Ltd 01.02.2022
John Wiley and Sons Inc
Subjects:
ISSN:0001-690X, 1600-0447, 1600-0447
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objective Meta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non‐suicidal self‐injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents. Methods An observational, longitudinal, retrospective study using a within‐subject study design including in‐ and outpatients aged 0–17 years treated with SSRIs. Data were obtained from digital medical records and prescription software. Results N = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive‐compulsive disorder. No suicides occurred. When comparing the 6‐week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non‐significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non‐significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4–14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2–3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1–4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2–3.5], p = 0.01). Conclusion Suicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.
AbstractList ObjectiveMeta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non‐suicidal self‐injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents.MethodsAn observational, longitudinal, retrospective study using a within‐subject study design including in‐ and outpatients aged 0–17 years treated with SSRIs. Data were obtained from digital medical records and prescription software.ResultsN = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive‐compulsive disorder. No suicides occurred. When comparing the 6‐week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non‐significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non‐significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4–14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2–3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1–4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2–3.5], p = 0.01).ConclusionSuicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.
Meta-analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non-suicidal self-injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents.OBJECTIVEMeta-analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non-suicidal self-injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents.An observational, longitudinal, retrospective study using a within-subject study design including in- and outpatients aged 0-17 years treated with SSRIs. Data were obtained from digital medical records and prescription software.METHODSAn observational, longitudinal, retrospective study using a within-subject study design including in- and outpatients aged 0-17 years treated with SSRIs. Data were obtained from digital medical records and prescription software.N = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive-compulsive disorder. No suicides occurred. When comparing the 6-week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non-significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non-significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4-14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2-3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1-4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2-3.5], p = 0.01).RESULTSN = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive-compulsive disorder. No suicides occurred. When comparing the 6-week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non-significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non-significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4-14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2-3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1-4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2-3.5], p = 0.01).Suicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.CONCLUSIONSuicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.
Objective Meta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non‐suicidal self‐injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents. Methods An observational, longitudinal, retrospective study using a within‐subject study design including in‐ and outpatients aged 0–17 years treated with SSRIs. Data were obtained from digital medical records and prescription software. Results N = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive‐compulsive disorder. No suicides occurred. When comparing the 6‐week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non‐significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non‐significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4–14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2–3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1–4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2–3.5], p = 0.01). Conclusion Suicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.
Meta-analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study investigates the risk and possible predictors of suicidality and non-suicidal self-injury (NSSI) associated with SSRI treatment in a clinical sample of children and adolescents. An observational, longitudinal, retrospective study using a within-subject study design including in- and outpatients aged 0-17 years treated with SSRIs. Data were obtained from digital medical records and prescription software. N = 365 patients were included (64.1% female), mean (SD) age 14.5 (2.04) years, with primary depression, anxiety or obsessive-compulsive disorder. No suicides occurred. When comparing the 6-week period immediately prior to versus following SSRI initiation, the patient proportion with broadly defined suicidality decreased (38.5% vs. 24.2%, p < 0.001) while the proportion with suicide attempts was stable (2.8% vs. 2.8%, p = 1.000). The proportion with NSSI decreased statistically non-significantly (12.4% vs. 8.4%, p = 0.067). Results from individually standardized observation periods were similar; however, the proportion with suicide attempts decreased statistically non-significantly and the proportion with NSSI decreased significantly. Suicidality during SSRI treatment was associated with previous suicidality (OR[CI] = 6.0 [2.4-14.8], p < 0.001), depression as indication for SSRI treatment (OR[CI] = 2.1 [1.2-3.7], p = 0.01), female sex (OR[CI] = 2.1 [1.1-4.1], p = 0.02) and previous NSSI (OR[CI] = 2.0 [1.2-3.5], p = 0.01). Suicidality was common in youth treated with SSRIs. The patient proportion with overall suicidality decreased, and the proportion with attempted suicide was stable in the weeks following SSRI initiation. Previous suicidality, depression, female sex and previous NSSI are important predictors for suicidality during SSRI treatment in youth.
Author Sørensen, Johanne Østerby
Verhulst, Frank C.
Rasmussen, Annette
Roesbjerg, Troels
Pagsberg, Anne Katrine
AuthorAffiliation 1 Child and Adolescent Mental Health Center Mental Health Services Capital Region of Denmark Hellerup Denmark
2 Mental Health Services Capital Region of Denmark Copenhagen Ø Denmark
3 Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
AuthorAffiliation_xml – name: 1 Child and Adolescent Mental Health Center Mental Health Services Capital Region of Denmark Hellerup Denmark
– name: 2 Mental Health Services Capital Region of Denmark Copenhagen Ø Denmark
– name: 3 Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
Author_xml – sequence: 1
  givenname: Johanne Østerby
  surname: Sørensen
  fullname: Sørensen, Johanne Østerby
  organization: Capital Region of Denmark
– sequence: 2
  givenname: Annette
  surname: Rasmussen
  fullname: Rasmussen, Annette
  organization: Capital Region of Denmark
– sequence: 3
  givenname: Troels
  surname: Roesbjerg
  fullname: Roesbjerg, Troels
  organization: Capital Region of Denmark
– sequence: 4
  givenname: Frank C.
  surname: Verhulst
  fullname: Verhulst, Frank C.
  organization: University of Copenhagen
– sequence: 5
  givenname: Anne Katrine
  surname: Pagsberg
  fullname: Pagsberg, Anne Katrine
  email: anne.katrine.pagsberg@regionh.dk
  organization: University of Copenhagen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34374070$$D View this record in MEDLINE/PubMed
BookMark eNp9kd9qFDEUxoNU7LZ64wPIgDciTk0ymUzGC6Es_oNChSp4F7KZM92zziZjktkydz6Cz-iTONOtRYuYm5wkv-_jnHxH5MB5B4Q8ZvSETeulsX08YUUh6T2yYJLSnApRHZAFpZTlsqZfDslRjJvpWDKqHpDDQhSVoBVdkN3FgBYb02EaM-OaLELX_vz-A91mCGN2hWk9X4FNuIOpCj55hy4LMPTJfIUM3RpXmHyIU5mNfkjrV9m5tUMI4Cy8yPoADdprYPZPuEV3-ZDcb00X4dHNfkw-v33zafk-Pzt_92F5epZbIRTNV7JoGqMsbUtpeVMwVktl21VrFS9Vy3hlikqpGkrbVKxVwgKwuhS1sUIKbopj8nrv2w-rLTQWXAqm033ArQmj9gb13y8O1_rS73TNa664nAye3RgE_22AmPQWo4WuMw78EDUvp_-WTPByQp_eQTd-CG4aT3PJGaWiYjP15M-Oblv5HckEPN8DNvgYA7S3CKN6zlvPeevrvCeY3oEtJpPQz9Ng928J20uusIPxP-b6dPnxYq_5BWkswPo
CitedBy_id crossref_primary_10_1111_sltb_13132
crossref_primary_10_3389_fpsyt_2022_990660
crossref_primary_10_5498_wjp_v15_i1_100308
crossref_primary_10_1089_cap_2023_29239_bjc
crossref_primary_10_3390_adolescents5010005
crossref_primary_10_1186_s12888_025_06735_1
crossref_primary_10_7759_cureus_31987
crossref_primary_10_1111_acps_13582
crossref_primary_10_1007_s00406_023_01584_z
crossref_primary_10_1016_j_jad_2023_01_061
Cites_doi 10.1016/j.euroneuro.2016.02.001
10.1111/jpc.12655
10.1136/bmj.g3596
10.1191/1740774506cn139oa
10.1176/appi.ajp.2008.08070976
10.1016/j.jaac.2015.05.004
10.2165/00128072-200305040-00004
10.1176/appi.ajp.2010.10050718
10.4088/JCP.08m04943
10.1503/cmaj.081514
10.1136/bmj.i65
10.1016/j.jaac.2018.01.015
10.1176/ajp.2007.164.7.1035
10.1089/cap.2006.16.91
10.1037/a0014732
10.1001/archpsyc.63.3.332
10.1038/sj.npp.1300996
10.1176/ps.2009.60.3.384
10.1080/13811110902834992
10.4088/JCP.08m04607
10.1176/appi.ajp.163.1.41
10.4103/sja.SJA_543_18
10.1037/0002-9432.75.2.324
10.1007/s00787-019-01435-0
10.1111/j.1440-1819.2011.02204.x
10.1007/s00787-018-01270-9
10.1001/jama.297.15.1683
10.1176/ajp.2007.164.7.1029
10.1016/j.jaac.2016.07.768
ContentType Journal Article
Copyright 2021 The Authors. published by John Wiley & Sons Ltd.
2021 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.
2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by John Wiley & Sons Ltd.
– notice: 2021 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.
– notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
DOI 10.1111/acps.13360
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate SØRENSEN et al
EISSN 1600-0447
EndPage 222
ExternalDocumentID PMC9292826
34374070
10_1111_acps_13360
ACPS13360
Genre article
Journal Article
Observational Study
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACHQT
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UPT
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YF5
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c4480-b63dda8c0f56c2d311968cfbfc8258f127a37889e5cd71f84cee19549ac4642a3
IEDL.DBID 24P
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000689482900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0001-690X
1600-0447
IngestDate Tue Nov 04 01:59:40 EST 2025
Sun Nov 09 11:55:41 EST 2025
Mon Oct 06 17:36:00 EDT 2025
Wed Feb 19 02:27:22 EST 2025
Tue Nov 18 22:38:15 EST 2025
Sat Nov 29 02:21:05 EST 2025
Wed Jan 22 16:27:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords serotonin reuptake inhibitors
suicidality
adolescents
children
non-suicidal self-injury
Language English
License Attribution-NonCommercial-NoDerivs
2021 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4480-b63dda8c0f56c2d311968cfbfc8258f127a37889e5cd71f84cee19549ac4642a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.13360
PMID 34374070
PQID 2621004715
PQPubID 33508
PageCount 0
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9292826
proquest_miscellaneous_2560061425
proquest_journals_2621004715
pubmed_primary_34374070
crossref_primary_10_1111_acps_13360
crossref_citationtrail_10_1111_acps_13360
wiley_primary_10_1111_acps_13360_ACPS13360
PublicationCentury 2000
PublicationDate February 2022
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: February 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Aalborg
– name: Hoboken
PublicationTitle Acta psychiatrica Scandinavica
PublicationTitleAlternate Acta Psychiatr Scand
PublicationYear 2022
Publisher Blackwell Publishing Ltd
John Wiley and Sons Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: John Wiley and Sons Inc
References 2006; 31
2009; 180
2009; 60
2006; 16
2019; 13
2007; 164
2015; 54
2006; 3
2012; 11
2016; 55
2009; 77
2014; 348
2011; 168
2009; 13
2006; 63
2009; 70
1990
2007; 297
2006; 163
2009; 166
2005; 75
2016; 352
2019; 29
2003; 5
2011; 65
2017
2014; 50
2016; 26
2020; 29
2018; 57
e_1_2_9_30_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
WHO (e_1_2_9_31_1) 1990
e_1_2_9_39_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_40_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
Hetrick SE (e_1_2_9_7_1) 2012; 11
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 54
  start-page: 557
  issue: 7
  year: 2015
  end-page: 564
  article-title: Systematic review and meta‐analysis: early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder
  publication-title: J Am Acad Child Adolesc Psychiatry
– volume: 164
  start-page: 1029
  issue: 7
  year: 2007
  end-page: 1034
  article-title: Suicide attempts among patients starting depression treatment with medications or psychotherapy
  publication-title: Am J Psychiatry
– volume: 65
  start-page: 239
  issue: 3
  year: 2011
  end-page: 245
  article-title: Suicide‐related events among child and adolescent patients during short‐term antidepressant therapy
  publication-title: Psychiatry Clin Neurosci
– volume: 57
  start-page: 235
  issue: 4
  year: 2018
  end-page: 244.e2
  article-title: The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta‐analysis
  publication-title: J Am Acad Child Adolesc Psychiatry
– volume: 75
  start-page: 324
  issue: 2
  year: 2005
  end-page: 333
  article-title: Self‐injurious behavior as a separate clinical syndrome
  publication-title: Am J Orthopsychiatry
– volume: 70
  start-page: 1069
  issue: 8
  year: 2009
  end-page: 1077
  article-title: Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case‐control study
  publication-title: J Clin Psychiatry
– volume: 16
  start-page: 91
  issue: 1–2
  year: 2006
  end-page: 102
  article-title: Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents
  publication-title: J Child Adolesc Psychopharmacol
– volume: 168
  start-page: 495
  issue: 5
  year: 2011
  end-page: 501
  article-title: Clinical and psychosocial predictors of suicide attempts and nonsuicidal self‐injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT)
  publication-title: Am J Psychiatry
– volume: 63
  start-page: 332
  issue: 3
  year: 2006
  end-page: 339
  article-title: Suicidality in pediatric patients treated with antidepressant drugs
  publication-title: Arch Gen Psychiatry
– volume: 3
  start-page: 73
  issue: 2
  year: 2006
  end-page: 90
  article-title: Do antidepressants cause suicidality in children? A Bayesian meta‐analysis
  publication-title: Clin Trials
– year: 1990
– volume: 29
  start-page: 759
  issue: 6
  year: 2019
  end-page: 776
  article-title: Psychosocial risk factors for suicidality in children and adolescents
  publication-title: Eur Child Adolesc Psychiatry
– volume: 50
  start-page: 847
  issue: 11
  year: 2014
  end-page: 854
  article-title: Do antidepressants make children and adolescents suicidal?
  publication-title: J Paediatr Child Health
– volume: 70
  start-page: 741
  issue: 5
  year: 2009
  end-page: 747
  article-title: Suicidal events in the Treatment for Adolescents With Depression Study (TADS)
  publication-title: J Clin Psychiatry
– volume: 11
  start-page: CD004851
  year: 2012
  article-title: Newer generation antidepressants for depressive disorders in children and adolescents
  publication-title: Cochrane Database Syst Rev
– volume: 348
  start-page: g3596
  year: 2014
  article-title: Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi‐experimental study
  publication-title: BMJ
– volume: 29
  start-page: 707
  issue: 5
  year: 2020
  end-page: 718
  article-title: Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents
  publication-title: Eur Child Adolesc Psychiatry
– volume: 180
  start-page: 291
  issue: 3
  year: 2009
  end-page: 297
  article-title: Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
  publication-title: CMAJ
– volume: 166
  start-page: 418
  issue: 4
  year: 2009
  end-page: 426
  article-title: Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI‐resistant depression in adolescents (TORDIA) study
  publication-title: Am J Psychiatry
– volume: 164
  start-page: 1035
  issue: 7
  year: 2007
  end-page: 1043
  article-title: Columbia Classification Algorithm of Suicide Assessment (C‐CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
  publication-title: Am J Psychiatry
– volume: 77
  start-page: 281
  issue: 2
  year: 2009
  end-page: 290
  article-title: Psychiatric diagnoses as contemporaneous risk factors for suicide attempts among adolescents and young adults: developmental changes
  publication-title: J Consult Clin Psychol
– volume: 163
  start-page: 41
  issue: 1
  year: 2006
  end-page: 47
  article-title: Suicide risk during antidepressant treatment
  publication-title: Am J Psychiatry
– volume: 297
  start-page: 1683
  issue: 15
  year: 2007
  end-page: 1696
  article-title: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta‐analysis of randomized controlled trials
  publication-title: JAMA
– volume: 13
  start-page: S31
  issue: Suppl 1
  year: 2019
  end-page: S34
  article-title: The STROBE guidelines
  publication-title: Saudi J Anaesth
– volume: 31
  start-page: 689
  issue: 4
  year: 2006
  end-page: 699
  article-title: The flawed basis for FDA post‐marketing safety decisions: the example of anti‐depressants and children
  publication-title: Neuropsychopharmacology
– volume: 26
  start-page: 411
  issue: 3
  year: 2016
  end-page: 419
  article-title: Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012
  publication-title: Eur Neuropsychopharmacol
– volume: 352
  start-page: i65
  year: 2016
  article-title: Suicidality and aggression during antidepressant treatment: systematic review and meta‐analyses based on clinical study reports
  publication-title: BMJ
– volume: 5
  start-page: 243
  issue: 4
  year: 2003
  end-page: 265
  article-title: Child and adolescent suicide: epidemiology, risk factors, and approaches to prevention
  publication-title: Paediatr Drugs
– volume: 3
  start-page: 73
  issue: 2
  year: 2006
  end-page: 90
  article-title: Comment to "Do antidepressants cause suicidality in children? A Bayesian meta‐analysis"
  publication-title: Clin Trials
– volume: 55
  start-page: 851
  issue: 10
  year: 2016
  end-page: 859.e2
  article-title: Systematic review and meta‐analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive‐compulsive disorder
  publication-title: J Am Acad Child Adolesc Psychiatry
– year: 2017
– volume: 60
  start-page: 384
  issue: 3
  year: 2009
  end-page: 386
  article-title: Are patients with depression at heightened risk of suicide as they begin to recover?
  publication-title: Psychiatr Serv
– volume: 13
  start-page: 105
  issue: 2
  year: 2009
  end-page: 122
  article-title: Predictors of non‐suicidal self‐injury versus attempted suicide: similar or different?
  publication-title: Arch Suicide Res
– ident: e_1_2_9_2_1
  doi: 10.1016/j.euroneuro.2016.02.001
– ident: e_1_2_9_4_1
  doi: 10.1111/jpc.12655
– ident: e_1_2_9_13_1
  doi: 10.1136/bmj.g3596
– ident: e_1_2_9_24_1
  doi: 10.1191/1740774506cn139oa
– ident: e_1_2_9_34_1
  doi: 10.1191/1740774506cn139oa
– ident: e_1_2_9_22_1
  doi: 10.1176/appi.ajp.2008.08070976
– ident: e_1_2_9_37_1
  doi: 10.1016/j.jaac.2015.05.004
– ident: e_1_2_9_18_1
  doi: 10.2165/00128072-200305040-00004
– ident: e_1_2_9_25_1
– ident: e_1_2_9_21_1
  doi: 10.1176/appi.ajp.2010.10050718
– ident: e_1_2_9_28_1
  doi: 10.4088/JCP.08m04943
– volume-title: International Statistical Classification of Diseases and Related Health Problems (ICD‐10)
  year: 1990
  ident: e_1_2_9_31_1
– ident: e_1_2_9_14_1
  doi: 10.1503/cmaj.081514
– ident: e_1_2_9_3_1
  doi: 10.1136/bmj.i65
– ident: e_1_2_9_39_1
  doi: 10.1016/j.jaac.2018.01.015
– ident: e_1_2_9_32_1
  doi: 10.1176/ajp.2007.164.7.1035
– ident: e_1_2_9_8_1
  doi: 10.1089/cap.2006.16.91
– ident: e_1_2_9_40_1
– ident: e_1_2_9_15_1
  doi: 10.1037/a0014732
– ident: e_1_2_9_6_1
  doi: 10.1001/archpsyc.63.3.332
– volume: 11
  start-page: CD004851
  year: 2012
  ident: e_1_2_9_7_1
  article-title: Newer generation antidepressants for depressive disorders in children and adolescents
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_9_10_1
– ident: e_1_2_9_12_1
  doi: 10.1038/sj.npp.1300996
– ident: e_1_2_9_26_1
  doi: 10.1176/ps.2009.60.3.384
– ident: e_1_2_9_35_1
  doi: 10.1080/13811110902834992
– ident: e_1_2_9_20_1
  doi: 10.4088/JCP.08m04607
– ident: e_1_2_9_27_1
  doi: 10.1176/appi.ajp.163.1.41
– ident: e_1_2_9_30_1
  doi: 10.4103/sja.SJA_543_18
– ident: e_1_2_9_33_1
– ident: e_1_2_9_36_1
  doi: 10.1037/0002-9432.75.2.324
– ident: e_1_2_9_29_1
  doi: 10.1007/s00787-019-01435-0
– ident: e_1_2_9_19_1
  doi: 10.1111/j.1440-1819.2011.02204.x
– ident: e_1_2_9_17_1
  doi: 10.1007/s00787-018-01270-9
– ident: e_1_2_9_23_1
  doi: 10.1191/1740774506cn139oa
– ident: e_1_2_9_9_1
– ident: e_1_2_9_11_1
– ident: e_1_2_9_5_1
  doi: 10.1001/jama.297.15.1683
– ident: e_1_2_9_16_1
  doi: 10.1176/ajp.2007.164.7.1029
– ident: e_1_2_9_38_1
  doi: 10.1016/j.jaac.2016.07.768
SSID ssj0005108
Score 2.4200141
Snippet Objective Meta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present...
Meta-analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present study...
ObjectiveMeta‐analyses have established a heightened risk of suicidality for youth treated with selective serotonin reuptake inhibitors (SSRIs). The present...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 209
SubjectTerms Adolescent
adolescents
Antidepressants
Child
children
Female
Humans
Male
Medical records
Mental depression
non‐suicidal self‐injury
Original
Patients
Retrospective Studies
Self destructive behavior
Self-Injurious Behavior - epidemiology
serotonin reuptake inhibitors
Serotonin uptake inhibitors
Serotonin Uptake Inhibitors - adverse effects
Suicidal Ideation
suicidality
Suicide
Suicides & suicide attempts
Title Suicidality and self‐injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.13360
https://www.ncbi.nlm.nih.gov/pubmed/34374070
https://www.proquest.com/docview/2621004715
https://www.proquest.com/docview/2560061425
https://pubmed.ncbi.nlm.nih.gov/PMC9292826
Volume 145
WOSCitedRecordID wos000689482900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1600-0447
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0005108
  issn: 0001-690X
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqFiEupZRHF0rlqlxABK2dhx3US1VYcWirFaVob5HjBw1U2VWSrcSNn9Df2F_CjJNNuypCQlwiK57Ez7Hn8-MbQl6lLDLWSRZIptIgyg0LUhXGgRsaYVyoXOSXLr4eiZMTOZmk4xWyv7gL0_JD9AtuqBl-vEYFV3l9S8mVntXvAGElANjXGAslOm7g0fjmgAcbtuMwAGbAgJOOnBTP8dx8uzwd3bEx7x6VvG3C-jlo9PD_cr9B1jvbkx60neURWbHlJrl_3O2uPyaXp3MIGW-ZU1UaWtsLd_3rqii_Q81TXLLFV-0QCaFq2uBiLq3sfNaoH5YW5XmRF-i_B4L0J3rne0-Rx7jydwrf0lmFiXkB_H-DLsW-PSFno49fDj8FnV-GQAOYGwZ5EhqjpB66ONHchAy0WGqXOw1wUzrGhUKW-tTG2gjmZAQTMRLLpUpHAHdU-JSsltPSbhGK9onkOdhohkUqBXTjXKwFVzoH0SQZkNeL5sl0R1qOvjMusgV4wYrMfEUOyF4vO2upOv4otb1o5axT1zrjCUfmPMHiAdnto0HRcPdElXY6Bxm0DcGY4SDzrO0UfTJhFApAxvBzsdRdegEk8V6OKYtzT-YNRYcagIK-8d3lLznPDg7Hpz70_F-EX5AHHK9s-JPm22S1qeb2JbmnL5uirna8ysBTTOQOWfvweXR29Bu5UyAZ
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYqqNpe-oR2gbau2guIoLXjvHpDqIiqy2olaLW3yPGDDaDsKptF4sZP4DfyS5hxsoEVFVLVm5VMEseZseebjL8h5FvChDY2Zl7MZOKJTDMvkX7g2a6OtPWlFS508acX9fvxcJgMmtwc3AtT80O0ATe0DDdfo4FjQPqelUs1me4AxAoBsS8LWGZQzbkY3GV4sG49EQNiBhA4bNhJMZHn7trF9eiBk_kwV_K-D-sWof1X_9n91-Rl433S3Vpd3pAnpnhLnh02_9ffkYujGbS0882pLDSdmnN7c3WdF6cw9hSDtnioniShVY4rDOfS0swmlTwzNC9GeZZjBR9o0kusz_edIpNx6XYVbtNJiQ9zAnj_CouKnayQ3_s_jvcOvKYyg6cAznW9LPS1lrHq2iBUXPsM7DhWNrMKAGdsGY8k8tQnJlA6YjYWsBQjtVwilQDAI_1VslSMC_OBUPRQYp6Bl6aZkAngG2sDFXGpMhANww7ZnH-fVDW05Vg94zydwxccyNQNZId8bWUnNVnHX6U25p85bQx2mvKQI3dexIIO-dKeBlPD_yeyMOMZyKB3CHrGQeZ9rRXtY3zhR4CN4ebRgr60AkjjvXimyEeOzhteHUYAXnTL6csjPU939wZHrrX2L8KfyfOD48Ne2vvZ_7VOXnDcwOHyzjfIUlXOzEfyVF1U-bT85OznFv2YIXw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5V26riUt6wpYARXEAErfMOt6plBWJZrShFe4scP2jaKhtls5V660_ob-wvYcbJpl0VISFuVjKx48fY89njbwDeJNxX2sTciblIHD9T3EmEFzhmoCJlPGF8u3XxcxSNx_F0mkxa3xy6C9PwQ3QbbqQZdr4mBdelMje0XMhy_gEhVoiIfd2nKDI9WN__PjwcXft48EEzFSNmRhg4bflJyZXn-uvVFemWmXnbW_KmFWuXoeHd_6zAPdhq7U-22wyY-7Cmiwew-a09YX8IZwcLTClrnTNRKDbXp-bq4jIvjrH1GW3b0qNmmsRUNatpQ5dVelHW4kSzvDjKs5xi-GCSnVOEvo-MuIwre6_wPSsrKswKUP41hRX79QgOh59-7H122tgMjkRAN3Cy0FNKxHJgglC6yuOoybE0mZEIOWPD3UgQU32iA6kibmIfF2Mil0uE9BHyCO8x9IpZoZ8CIxsldjO00xT3RYIIx5hARq6QGYqGYR_eLvsnlS1xOcXPOE2XAIYaMrUN2YfXnWzZ0HX8UWpn2c1pq7Lz1A1dYs-LeNCHV91rVDY6QRGFni1QhuxDNGhclHnSjIquGM_3IkTHmHm0Ml46ASLyXn1T5EeW0Burji2AFX1nx8tf_jzd3Zsc2NT2vwi_hM3J_jAdfRl_fQZ3XLrBYR3Pd6BXVwv9HDbkWZ3PqxetAv0GkfIikg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Suicidality+and+self-injury+with+selective+serotonin+reuptake+inhibitors+in+youth%3A+Occurrence%2C+predictors+and+timing&rft.jtitle=Acta+psychiatrica+Scandinavica&rft.au=S%C3%B8rensen%2C+Johanne+%C3%98sterby&rft.au=Rasmussen%2C+Annette&rft.au=Roesbjerg%2C+Troels&rft.au=Verhulst%2C+Frank+C&rft.date=2022-02-01&rft.eissn=1600-0447&rft.volume=145&rft.issue=2&rft.spage=209&rft_id=info:doi/10.1111%2Facps.13360&rft_id=info%3Apmid%2F34374070&rft.externalDocID=34374070
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-690X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-690X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-690X&client=summon